Your search for comorbidities returned 77 results

Investigators examined the relationship between trends in primary and secondary vascular access sites and vascular access site complications among a cohort of patients who underwent PCI.

The overall prevalence of Kounis syndrome in the United States is 1.1% among patients hospitalized for allergic/hypersensitivity/anaphylactic reactions, with a 7.0% rate of all-cause inpatient mortality.

Sodium-glucose cotransporter 2 inhibitors use may reduce cardiac arrhythmia risk, including the risk for atrial fibrillation.

The long-term risk for a venous thromboembolism event was found to be associated with the occurrence of heart failure with preserved or reduced ejection fraction, and with left ventricular remodeling.

The researchers sought to determine whether an interatrial shunt device would improve pulmonary artery function at rest and during exercise in patients without heart failure without lessening systemic blood flow.

The risk for death in patients undergoing anticoagulation therapy for venous thromboembolism was found to be lower in those who were morbidly obese vs those who had normal weight.

A systematic review and meta-analysis was conducted to look at the effects of body mass index on atrial fibrillation‐related outcomes in anticoagulated patients.

Researchers evaluated the safety and efficacy of firibastat to lower blood pressure in a diverse high-risk population of patients with hypertension.

Researchers sought to determine if peripheral artery disease is an independent risk factor for heart failure.

A study was conducted to determine if CO2 angiography during PVI in patients with advanced chronic kidney disease can decrease postcontrast AKI.